| Listed site | cdmo | cdmo |
|---|
| Summary | CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management. | Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services. |
|---|
| Services | - CMC Analytical Development
- Formulation Development
- Process Development
- Technology Transfer
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Peptide Manufacturing
- ADC Payload & Linker Synthesis
- ADC (Antibody-Drug Conjugate) Manufacturing
- Oral Solid Dosage Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vaccine Manufacturing
- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Bioconjugation Services
- Monoclonal Antibody (mAb) Manufacturing
- CMC Regulatory Submission Support
| - Cell-Line Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- CMC Regulatory Submission Support
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- mRNA Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Biologics Development & Manufacturing
- Upstream Processing
- Downstream Processing
- Vial Filling
- Stability Testing & Storage
- Formulation Development
- Vaccine Manufacturing
- ADC Payload & Linker Synthesis
- Lipid Nanoparticle (LNP) Formulation
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
|
|---|
| Modalities | - Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Peptide
- Vaccine
| - Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- mRNA
- Vaccine
|
|---|
| Indications | Data not yet provided. | |
|---|
| Locations | - Grangemouth, Grangemouth, Scotland, United Kingdom
- Shanghai, Shanghai, China
- Sourcing Office, Shanghai, China
| - Bio Campus I, South Korea
- Bio Campus II, South Korea
- Headquarters / Bio Campus I, Incheon, Yeonsu-gu, Republic of Korea
- Bio Campus II, Incheon, Yeonsu-gu, Republic of Korea
- ADC Plant, Incheon, Yeonsu-gu, Republic of Korea
- Samsung Biologics America, United States
- Samsung Biologics Japan Office, Japan
- Headquarters
|
|---|
| Certifications | - MHRA · Identifier: GMP Certificate
- GMP · Identifier: GMP
- ISO · Identifier: ISO 9001, 14001, 45001
- FAMI-QS · Identifier: FAMI-QS
- ISO · Identifier: ISO 9001
- ISO · Identifier: ISO 14001
- ISO · Identifier: ISO 45001
| Data not yet provided. |
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|